Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06294587 · ClinicalTrials.gov registry record · NA

Evaluation of Free Gingival Graft Timing

A NA study of Ridge Augmentation and Alveolar Mucosa, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06294587 is a NA study of Ridge Augmentation and Alveolar Mucosa that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06294587, a NA study of Ridge Augmentation and Alveolar Mucosa, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This clinical trial aims to compare and evaluate the clinical outcomes between two distinct treatment sequences: free gingival graft surgery preceding guided bone regeneration and guided bone regeneration followed by free gingival graft.

Interventions

  • PROCEDURE FGG Before GBR
  • PROCEDURE FGG after GBR

Study Locations (1)

Alabama

  • Unversity of Alabama at Birmingham, School of Dentistry - Birmingham

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-08-12
Est. Completion 2027-08-30
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT06294587

The ClinicalTrials.gov registry entry for NCT06294587 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Ridge Augmentation appearing as the primary indexed condition, and to 2 interventions - of which FGG Before GBR is the first listed.

NCT06294587 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT06294587 about?

NCT06294587 is a clinical study titled "Evaluation of Free Gingival Graft Timing". This clinical trial aims to compare and evaluate the clinical outcomes between two distinct treatment sequences: free gingival graft surgery preceding guided bone regeneration and guided bone regeneration followed by free gingival graft.

What is the current status of trial NCT06294587?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-08-12. Estimated completion is 2027-08-30.

What conditions does trial NCT06294587 study?

This clinical trial studies the following conditions: Ridge Augmentation, Alveolar Mucosa.

What interventions are being tested in trial NCT06294587?

The interventions under investigation include: FGG Before GBR (PROCEDURE), FGG after GBR (PROCEDURE).

Who is sponsoring clinical trial NCT06294587?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06294587 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ridge Augmentation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.